Experimental Drug Yields Dramatic Weight Loss
May 21, 2026
6:23 pm
Empowering Traders, Illuminating Opportunities, and Navigating the Markets Together.
Ready to take your stock trading to the next level? Sign up now to receive exclusive market analyses, insightful tips, and valuable resources straight to your inbox. Don’t miss out on the opportunity to stay ahead in the ever-evolving world of trading!
Alphabet‘s Google (NASDAQ:GOOGL) (NASDAQ:GOOG) is reportedly developing an AI personal agent for its Gemini app, capable of performing tasks on behalf of the user. Google
Inhibrx Biosciences Inc. (NASDAQ:INBX) is attracting interest from major drugmakers for its experimental cancer therapy INBRX-106, which could be valued at over $8 billion. • Inhibrx
Spirit Aviation Holdings Inc. (OTC:FLYYQ) could reportedly halt operations within days as the creditors raise doubts about the company’s ability to clear dues. Spirit To
Microsoft has not made the Maia 200 chips available to customers, but
The Securities and Exchange Commission today rescinded a policy, codified in Rule
Law Offices of Howard G. Smith reminds investors of the upcoming July 17, 2026 deadline to file a lead plaintiff motion in the case filed
For years, payroll and HR have weighed down SMEs, tangled in complexity, bureaucracy, and endless regulation. PayFit is dismantling that friction, automating payroll and compliance
The following looks at the fintech, digital and wider economic development of the Southern European country of Croatia in a 2026 context. Croatia’s digital economy
Become a part of the growing team. Don’t miss a single opportunity!
Enter your favorite stock symbol and customize your chart.
Stephen Colbert’s “Colbert Report” satirized politics. Then his “Late Show” confronted a moment when politics became self-satirizing.Read
On Friday, President Donald Trump distanced himself from reports that his administration
Gain insights, receive dynamic opportunities directly to your inbox. Sign up now…